Cytophage Technologies Ltd.
CPTCF
$0.21
$0.0747.71%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -751.70K | -816.50K | -808.40K | -887.60K | -798.70K |
| Total Depreciation and Amortization | 62.90K | 130.20K | 177.50K | 127.40K | 130.20K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 67.10K | 13.50K | 16.30K | 36.00K | -6.60K |
| Change in Net Operating Assets | 40.70K | 17.70K | 107.30K | 183.50K | 40.00K |
| Cash from Operations | -581.00K | -655.20K | -507.30K | -540.80K | -635.20K |
| Capital Expenditure | -6.70K | 0.00 | -2.20K | -71.50K | -266.60K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -160.70K | 0.00 |
| Cash from Investing | -6.70K | 0.00 | -2.20K | -232.20K | -266.60K |
| Total Debt Issued | -- | -- | -- | 225.00K | -- |
| Total Debt Repaid | -74.60K | -74.60K | -74.60K | 27.70K | -74.60K |
| Issuance of Common Stock | 0.00 | 1.55M | -- | -- | 0.00 |
| Repurchase of Common Stock | -- | -- | -- | -2.50M | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | -58.80K | -- | 2.50M | 0.00 |
| Cash from Financing | -54.20K | 1.02M | -52.00K | 180.50K | -54.70K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -641.90K | 368.70K | -561.40K | -592.50K | -956.50K |